Nuveen Asset Management »

Celldex Therapeutics shares owned by Nuveen Asset Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Nuveen Asset Management from 13F filings

Historical chart of Nuveen Asset Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Nuveen Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Nuveen Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $16M 432k 37.01
2024-03-31 $16M 369k 41.97
2023-09-30 $3.3M 120k 27.52
2023-06-30 $4.1M 121k 33.93
2023-03-31 $4.3M 121k 35.98
2022-12-31 $5.8M 130k 44.57
2022-09-30 $4.2M 150k 28.11
2022-06-30 $4.2M 154k 26.96
2022-03-31 $4.6M 134k 33.98
2021-12-31 $5.0M 137k 36.31
2021-09-30 $8.0M 148k 54.39
2021-06-30 $4.8M 142k 33.44